TriangleHEALTH PROFESSIONAL · SOURCE READING
Prognostic scoring systems
Source: Malignant Mesothelioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: General Information About Malignant Mesothelioma Treatment / Diagnosis and Prognostic Factors
Two prognostic scoring systems have been developed for advanced unresectable mesothelioma and are used to stratify patients enrolling in clinical trials: the Cancer and Leukemia Group B (CALGB) index and the European Organisation for the Research and Treatment of Cancer (EORTC) index.
Continue within this section
Preserved source evidence · Not medical advice